Milt Childress
Analyst · KeyBanc Capital Markets. Please proceed with your question
Thanks, Eric. As Eric mentioned, we had another exceptional quarter, positive momentum across most major end markets, as well as the addition of Alluxa contributed to strong top-line results, partially offset by the reduction in sales due to last year's divestitures. As reported, sales of $298.6 million in the second quarter increased 20.9% year-over-year. Organic sales for the quarter increased 27.1% compared to the second quarter of 2020. As Eric noted, sequentially, sales were up 6.9%. Gross profit margin of 39.2% increased 580 basis points versus the prior year period. The increase was driven primarily by strong organic sales volume and the benefit of divesting lower margin businesses. Adjusted EBITDA of $57.2 million increased 52.5% over the prior year period as a result of higher operating leverage from solid organic sales growth, the addition of Alluxa and increased pricing, partially offset by increased raw material costs and higher incentive compensation accruals. Adjusted EBITDA margin of 19.2% increased approximately 400 basis points compared to the second quarter of 2020. Corporate expenses of $12.8 million in the second quarter of 2021 increased from $7.1 million a year ago. The increase was driven primarily by higher incentive compensation accruals, reflecting the stronger year-over-year performance company wide. Adjusted diluted earnings per share of $1.56 increased 77.3% compared to the prior year period. As noted during prior calls, during the fourth quarter of 2020, we changed our adjusted EPS from the previous presentation of this non-GAAP measure to one that excludes after-tax acquisition-related intangible amortization. Amortization of acquisition-related intangible assets in the second quarter was $11.3 million compared to $9 million in the prior year period, reflecting the addition of Alluxa. We anticipate amortization of acquisition-related intangibles will be between $44 million and $46 million in 2021. As a reminder, our estimated normalized tax rate used in determining adjusted EPS is 30%. Moving to a discussion of segment performance. Sealing Technologies sales of $162.5 million increased 7.9% compared to the prior year period despite the impact of divestitures in 2020. Excluding the impact of foreign exchange translation and divested businesses, sales increased 25.3%, driven by strong demand in the heavy-duty truck, general industrial, food and pharma and petrochemical markets, offset partially by power generation and aerospace markets. Sequentially, sales increased 10.9% as we saw momentum accelerate in our heavy-duty truck, general industrial, aerospace and petrochemical markets. For the second quarter, adjusted segment EBITDA increased 39% to $42.4 million, and adjusted segment EBITDA margin expanded 580 basis points to 26.1%. The margin expansion was driven primarily by operating leverage commensurate with strong volume, portfolio reshaping, select pricing actions and continuous improvement initiatives. Excluding the impact of favorable foreign exchange translation and divestitures, adjusted segment EBITDA increased 45.6% compared to the prior year period. Turning now to Advanced Surface Technologies. Second quarter sales of $59.2 million increased 48%, driven by continued strong growth in semiconductor and the addition of Alluxa. Excluding the impact of foreign exchange translation and the Alluxa acquisition, sales increased 23.8% versus the prior year period. Sequentially, sales increased 8.2%, driven by growth in semiconductor markets. For the second quarter, adjusted segment EBITDA increased 41.8% to $15.6 million, and adjusted segment EBITDA margin contracted from 27.5% a year ago to 26.4%. Excluding the impact of Alluxa and foreign exchange translation, adjusted segment EBITDA remained unchanged. Results for the quarter were impacted by increased operating costs related to the stand-up and qualification of the third LeanTeq facility in Taiwan and by foreign exchange transactional charges. As a reminder, LeanTeq is a highly differentiated cleaning, coding and related service provider with industry-leading solutions that support the most advanced technology nodes within the semiconductor industry, a high growth market that has strong secular tailwinds. The new facility nearly doubles our capacity in Taiwan. More broadly, across the entire AST segment, we continue to see secular growth signals and expect sustained organic revenue growth and strong profitability over the long term. In Engineered Materials, second quarter sales of $80 million increased 36.5% compared to the prior year, driven by stronger sales in all major markets, including general industrial, automotive, oil and gas and petrochemical. Excluding the impact of foreign exchange translation and the divestiture of GGB's Bushing Block business completed in the fourth quarter of last year, sales for the quarter increased 34.2%. Sequentially, sales were flat when compared to a very strong first quarter. We saw a quarter-over-quarter sales growth in petrochemical and oil and gas markets, offset by slower automotive production environment due to the supply chain constraints affecting that market. Based on conversations with automotive customers, we believe that sales growth will resume in the latter part of the second half of the year as supply chain shortages are resolved and production schedules normalize. Second quarter adjusted segment EBITDA increased 165% over the prior year period to $13 million, and adjusted segment EBITDA margin expanded 790 basis points to 16.3%. The strong year-over-year increase in EBITDA and EBITDA margins was driven primarily by the brisk volume recovery from the pandemic low, partially offset by increased material costs. Excluding the favorable impact of foreign exchange translation and the impact of the Bushing Block business divestiture, adjusted EBITDA increased 155% compared to the prior year period. Now let's turn to the balance sheet and cash flow. We ended the quarter with cash of $262 million and full availability of our $400 million revolver, less $11 million in outstanding letters of credit. At the end of June, our net debt to adjusted EBITDA ratio was approximately one times, a sequential improvement from the 1.4 times reported at the end of the first quarter. Our balance sheet remains solid, and we have ample financial flexibility to execute our strategic growth initiatives. Free cash flow for the first six months of 2021 was $48 million, up from $25 million in the prior year, driven primarily by higher operating profits, offset partially by working capital investments supporting stronger sales. During the second quarter, we paid a $0.27 per share quarterly dividend. For the first six months of the year, dividend payments totaled $11.3 million, a 4.6% increase versus the prior year. Moving now to 2021 guidance. Taking into consideration all the factors that we know at this time, including current order patterns, we are increasing our guidance for 2021 adjusted EBITDA to be in the range of $200 million to $210 million, up from our previous guidance of $190 million to $200 million. The updated adjusted EBITDA range is based on sales growth of 9% to 14% over 2020 pro-forma sales of $983 million, up from a previous range of 7% to 12% growth. We expect adjusted diluted earnings per share from continuing operations to be in the range of $5.16 to $5.50, up from a range of $4.74 to $5.08 provided last quarter. Our guidance assumes depreciation and amortization expense, excluding amortization of acquisition-related intangible assets in the range of $30 million to $32 million and net interest expense of $14 million to $16 million. Like each of you, we continue to monitor developments around COVID-19 and new variant. And we'll evaluate potential impacts of such developments on our business, while focusing on the health and safety of our colleagues. Now I'll turn the call back to Eric for closing comments.